Document:

Exhibit 10.8 

EMPLOYMENT AGREEMENT 

        THIS
EMPLOYMENT AGREEMENT (this “Agreement”) is made as of December 31, 2006,
by Security With Advanced Technology, Inc., a Colorado corporation (the “Employer”),
and Scott G. Sutton, an individual who is a resident of Broomfield, Colorado (the
“Executive”). 

RECITALS 

        WHEREAS,
 the Employer wishes to employ Executive upon
the terms and conditions set forth in this Agreement; and  

        WHEREAS, the
Employee wishes to be employed upon the terms and conditions set forth herein.  

AGREEMENT 

        The
parties, intending to be legally bound, agree as follows: 

1.     DEFINITIONS  

        For the
purposes of this Agreement, the following terms have the meanings specified or referred to
in this Section 1. 

        “Agreement”
means this Employment Agreement, as amended, restated or otherwise modified from time to
time. 

        “Basic
Compensation” means Salary and Benefits. 

        “Benefits” is
defined in Section 3.3.  

        “Board
of Directors” means the board of directors of the Employer. 

        “Change
in Control” means (a) the acquisition, directly or indirectly, by any person or
group (within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934) of
the beneficial ownership of more than 50% of the outstanding securities of the Employer;
(b) a merger or consolidation in which the Employer is not the surviving entity, except
for a transaction the principal purpose of which is to change the state in which the
Employer is incorporated; (c) sale, transfer or other disposition of all or substantially
all of the assets of the Employer; (d) a complete liquidation or dissolution of the
Employer; or (e) any reverse merger in which the Employer is the surviving entity but in
which securities possessing more than 50% of the total combined voting power of the
Employer’s outstanding securities are transferred to a person or persons different
from the person’s holding those securities immediately prior to such merger. 

        “Confidential
Information” means any and all: 

1 

         
        (a)       
          trade secrets concerning the business and affairs of the Employer, product
          specifications, data, know-how, formulae, compositions, processes, designs,
          sketches, photographs, graphs, drawings, samples, inventions and ideas, past,
          current, and planned research and development, current and planned manufacturing
          or distribution methods and processes, customer lists, current and anticipated
          customer requirements, price lists, market studies, business plans, computer
          software and programs (including object code and source code), computer software
          and database technologies, systems, structures, and architectures (and related
          formulae, compositions, processes, improvements, devices, know-how, inventions,
          discoveries, concepts, ideas, designs, methods and information), and any other
          information, however documented, that is a trade secret within the meaning of
          the Colorado Uniform Trade Secrets Act, as in effect as of the date hereof and
          as amended from time to time. 

         
        (b)       
          information concerning the business and affairs of the Employer (which includes
          historical financial statements, financial projections and budgets, historical
          and projected sales, capital spending budgets and plans, the names and
          backgrounds of key personnel and personnel training and techniques and
          materials), however documented; and 

         
        (c)       
          notes, analysis, compilations, studies, summaries, and other material prepared
          by or for the Employer containing or based, in whole or in part, on any
          information included in the foregoing. 

        “disability”
is defined in Section 6.2. 

        “Effective
Date” means the date stated in the first paragraph of this Agreement. 

        “Employee
Invention” means any idea, invention, technique, modification, process, or
improvement (whether patentable or not), any industrial design (whether registrable or
not), any mask work, however fixed or encoded, that is suitable to be fixed, embedded or
programmed in a semiconductor product (whether recordable or not), and any work of
authorship (whether or not copyright protection may be obtained for it) created,
conceived, or developed by the Executive, either solely or in conjunction with others,
during the Employment Period, or a period that includes a portion of the Employment
Period, that relates in any way to, or is useful in any manner in the business then being
conducted or proposed to be conducted by the Employer, and any such item created by the
Executive, either solely or in conjunction with others, following termination of the
Executive’s employment with the Employer, that is based upon or uses Confidential
Information. 

        “Employment
Period” means the term of the Executive’s employment under this Agreement. 

        “Fiscal
Year” means the Employer’s fiscal year, as it exists on the Effective Date,
which on the Effective Date is the calendar year. 

        “for
cause” is defined in Section 6.3. 

        “for good
reason” is defined in Section 6.4. 

2 

        “person”
means any individual, corporation (including any non-profit corporation), general or
limited partnership, limited liability company, joint venture, estate, trust, association,
organization, or governmental body. 

        “Post-Employment
Period” is defined in Section 8.2. 

        “Proprietary
Items” is defined in Section 7.2(a)(iv). 

        “Salary”is
defined in Section 3.1.  

2.    EMPLOYMENT
TERMS AND DUTIES 

    
  2.1        Employment.
The Employer hereby employs the Executive, and the Executive hereby accepts employment by
the Employer, upon the terms and conditions set forth in this Agreement.  

    
  2.2        Basic
Term. Subject to the provisions of Section 6, the basic term of the
Executive’s employment under this Agreement will begin on the Effective Date and end
two years and one day from the Effective Date.  

      2.3        Duties.
The Executive will have such duties as are assigned or delegated to the Executive by the
Board of Directors, and will initially serve as President of the Employer. The Executive
will devote all of his business time, attention, skill, and energy to the business of the
Employer, will use his best efforts to promote the success of the Employer’s
business, and will cooperate fully with the Board of Directors in the advancement of the
best interests of the Employer. Nothing in this Section 2.3, however, will prevent
the Executive from engaging in additional activities in connection with personal
investments and community affairs that are not inconsistent with the Executive’s
duties under this Agreement. In addition, provided that Executive obtains the advance
written consent of the Board of Directors, Executive may serve on the board of directors
of other companies, with any current board positions of the Executive, being accepted as
of the date of this Agreement. If the Executive is elected as a director of the Employer
or as a director or officer of any of its affiliates, the Executive will fulfill his
duties as such director or officer without additional compensation.  

3.     COMPENSATION  

       3.1        Salary.
The Executive will be paid an annual salary of $140,000, subject to adjustment as
provided below (the “Salary”), which will be payable in equal periodic
installments according to the Employer’s customary payroll practices, but no less
frequently than monthly. The Salary may be reviewed by the Board of Directors, and may be
adjusted upward, but not downward in the sole discretion of the Board of Directors.  

       3.2        Bonus.
The Board of Directors will create a bonus plan for executive officers, which shall
include the Executive. The terms, objectives and amounts of the bonus plan will be
determined by the Board of Directors.  

3 

       3.3        Benefits.
The Executive will, during the Employment Period, be permitted to participate in such
hospitalization, major medical, and other employee benefit plans of the Employer that may
be in effect from time to time, to the extent the Executive is eligible under the terms
of those plans (collectively, the “Benefits”).  

4.     FACILITIES
AND EXPENSES.  

        The
Employer will furnish the Executive office space, equipment, supplies, and such other
facilities and personnel, as the Employer deems necessary or appropriate for the
performance of the Executive’s duties under this Agreement. The Employer will pay
the Executive’s dues in such professional societies and organizations as the Board
of Directors deems appropriate, and will pay on behalf of the Executive (or reimburse the
Executive for) reasonable expenses incurred by the Executive at the request of, or on
behalf of, the Employer in the performance of the Executive’s duties pursuant to
this Agreement, and in accordance with the Employer’s employment policies, including
reasonable expenses incurred by the Executive in attending conventions, seminars, and
other business meetings, in appropriate business entertainment activities, and for
promotional expenses. The Executive must file expense reports with respect to such
expenses in accordance with the Employer’s policies. All expenses shall be
reimbursed within 30 days of submission of appropriate expense reports.  

5.     VACATIONS
AND HOLIDAYS  

        The
Executive will be entitled to four weeks’ paid vacation each Fiscal Year in
accordance with the vacation policies of the Employer in effect for its executive officers
from time to time. Such policies may include provisions for carryover of unused vacation
as well as requirements to secure advance approval for carryover of unused vacation hours.
The Executive will also be entitled to the paid holidays set forth in the Employer’s
policies. If the Executive is unable to perform his duties for physical or mental reasons,
then Employer shall provide Executive with his Basic Compensation until Executive’s
employment is terminated due to the disability of the Executive. 

6.     TERMINATION  

    
    6.1        Events
of Termination. The Employment Period, the Executive’s Basic Compensation, and
any and all other rights of the Executive under this Agreement or otherwise as an
employee of the Employer will terminate (except as otherwise provided in this Section 6):  

    
            (a)                 upon
the death of the Executive;  

         
            (b)       
          upon the disability of the Executive (as defined in Section 6.2)
          immediately upon notice from either party to the other; 

         
            (c)        
          for cause (as defined in Section 6.3), as determined by the Board of
          Directors immediately upon notice from the Employer to the Executive, or at such
          later time as such notice may specify; 

4 

         
            (d)       
          for good reason (as defined in Section 6.4) upon not less than 30
          days’ prior notice from the Executive to the Employer, which notice
          specifies the Executive’s intent to terminate this Agreement and the
          factual basis for such termination, it being understood that if the Employer can
          cure the problem giving rise to such termination within such 30-day period, the
          termination will not occur; or 

         
            (e)       
          upon notice by the Board of Directors. 

    6.2        Definition
of “Disability.” For purposes of Section 6, the Executive will
be deemed to have a “disability” if, for physical or mental reasons, the
Executive is unable to perform the Executive’s duties under this Agreement for 90
consecutive days, or 120 days during any 12-month period, as determined in accordance
with this Section 6.2. The disability of the Executive will be determined by a
medical doctor selected by written agreement of the Employer and the Executive upon the
request of either party by notice to the other. If the Employer and the Executive cannot
agree on the selection of a medical doctor, each of them will select a medical doctor and
the two medical doctors will select a third medical doctor who will determine whether the
Executive has a disability. The determination of the medical doctor selected under this
Section 6.2 will be binding on both parties. The Executive must submit to a
reasonable number of examinations by the medical doctor making the determination of
disability under this Section 6.2, and the Executive hereby authorizes the
disclosure and release to the Employer of such determination and all supporting medical
records. If the Executive is not legally competent, the Executive’s legal guardian
or duly authorized attorney-in-fact will act in the Executive’s stead, under this Section
6.2, for the purposes of submitting the Executive to the examinations, and providing
the authorization of disclosure, required under this Section 6.2.  

    6.3        Definition
of “For Cause.” For purposes of Section 6, the phrase “for
cause” means: (a) the Executive’s material breach of this Agreement; (b) the
Executive’s willful failure to adhere to any written Employer policy if the
Executive has been given a reasonable opportunity to comply with such policy or cure his
failure to comply (which reasonable opportunity must be granted during the 10-day period
preceding termination of this Agreement); (c) the appropriation (or attempted
appropriation) of a material business opportunity of the Employer, including attempting
to secure or securing any personal profit in connection with any transaction entered into
on behalf of the Employer; (d) the misappropriation (or attempted misappropriation) of
any of the Employer’s funds or property; or (e) the conviction of, the indictment
for (or its procedural equivalent), or the entering of a guilty plea or plea of no
contest with respect to, a felony.  

    6.4        Definition
of “For Good Reason.” For purposes of Section 6, the phrase
“for good reason” means: (a) the Employer’s material breach of this
Agreement; or (b) a material reduction in Executive’s position, duties and
responsibilities from those described in Section 2.3 of this Agreement.  

5 

    6.5        Termination
Pay. Effective upon the termination of this Agreement during the term specified in
Section 2.2, the Employer will be obligated to pay the Executive (or, in the event of his
death, his designated beneficiary as defined below) only such compensation as is provided
in this Section 6.5, and in lieu of all other amounts and in settlement and
complete release of all claims the Executive may have against the Employer (as set forth
in a valid release of the Employer and its agents and affiliates signed by the
Executive). For purposes of this Section 6.5, the Executive’s designated
beneficiary will be such individual beneficiary or trust, located at such address, as the
Executive may designate by notice to the Employer from time to time or, if the Executive
fails to give notice to the Employer of such a beneficiary, the Executive’s estate.
Notwithstanding the preceding sentence, the Employer will have no duty, in any
circumstances, to attempt to open an estate on behalf of the Executive, to determine
whether any beneficiary designated by the Executive is alive or to ascertain the address
of any such beneficiary, to determine the existence of any trust, to determine whether
any person or entity purporting to act as the Executive’s personal representative
(or the trustee of a trust established by the Executive) is duly authorized to act in
that capacity, or to locate or attempt to locate any beneficiary, personal
representative, or trustee.  

         
        (a)       
Termination by the Executive for Good Reason.
If the Executive terminates this Agreement for good reason, the Employer will pay the Executive the
Executive’s Salary in periodic installments according to the Employer’s customary payroll practices until six
months after the date such termination is effective. In addition, if the Executive terminates this Agreement for
good reason, an amount equal to 66.67% of the Executive's pro rata portion
(which portion shall include, for purposes of this Agreement, Sandy Sutton's pro rata portion) of the unearned Earn-Out (as defined
in the Plan of Merger dated as of September 3, 2006, by and among the Employer, Vizer Merger Sub, Inc., Vizer
Group, Inc., Avurt International, Inc., the Executive, Sandy Sutton and Michael Cox (the "Plan of Merger"))
shall be deemed earned in full and be payable in equal monthly installments over the number of full months
remaining in the Earn-Out Period (as defined in the Plan of Merger). The unearned portion of the Earn-Out shall
be determined by the following formula: (i) $2,000,000; less (ii) all amounts previously earned (whether paid or
payable) under the Earn-Out. Except as specifically set forth in this Section 6.5(a), the amount payable under
this Section 6.5(a) shall be paid in accordance with the terms of the Plan of Merger. 

         
        (b)       
          Termination by the Employer for Cause. If the Employer terminates this
          Agreement for cause, the Executive will be entitled to receive his Salary only
          through the date such termination is effective. 

         
        (c)       
          Termination upon Disability. If this Agreement is terminated by either
          party as a result of the Executive’s disability, as determined under
          Section 6.2, the Employer will pay the Executive the Executive’s
          Salary in periodic installments according to the Employer’s customary
          payroll practices until six months after the date such termination is effective. 

         
        (d)       
          Termination upon Death. If this Agreement is terminated because of the
          Executive’s death, the Executive will be entitled to receive the
          Executive’s Salary in periodic installments according to the
          Employer’s customary payroll practices until six months after the date such
          termination is effective. 

6 

         
        (e)       
          Termination Upon Notice by the Board of Directors. If the Board of
          Directors provides notice of termination of this Agreement which is not for
          cause, then the Employer will pay the Executive the Executive’s Salary in
          periodic installments according to the Employer’s customary payroll
          practices until six months after the date such termination is effective. In
          addition, if the Board of Directors provides notice of termination of this
          Agreement which is not for cause, an amount equal to 66.67% of the
          Executive’s pro rata portion (which portion shall include, for purposes of this Agreement, Sandy Sutton's pro rata portion)
  of the unearned Earn-Out
          (as defined in the Plan of Merger) shall be deemed earned in full and be payable
          in equal monthly installments over the number of full months remaining in the
          Earn-Out Period (as defined in the Plan of Merger).  The unearned portion
          of the Earn-Out shall be determined by the following formula: (i) $2,000,000;
          less (ii) all amounts previously earned (whether paid or payable) under the
          Earn-Out.  Except as specifically set forth in this Section
          6.5(e), the amount payable under this Section 6.5(e) shall be paid in
          accordance with the terms of the Plan of Merger. 

         
        (f)       
          Benefits. The Executive’s accrual of, or participation in plans
          providing for, the Benefits will cease at the effective date of the termination
          of this Agreement, and the Executive will be entitled to accrued Benefits
          pursuant to such plans only as provided in such plans; provided, that, if this
          Agreement is terminated pursuant to Sections 6.1 (a), (c) or
          (e), then the Executive will be entitled to continue to receive his
          Benefits until six months after the date such termination is effective. The
          Executive will receive, as part of his termination pay pursuant to this
          Section 6, compensation for any accrued but unused vacation pay on the date
          the notice of termination is given under this Agreement. 

    
        (g)           Termination
After Change in Control. Notwithstanding the foregoing, if           the Executive’s
employment is terminated pursuant to Section 6.1(d) or           6.1(e) at any time
within 90 days following a Change in Control, then the           Employer will pay the
Executive his salary in periodic installments according to           the Employer’s
customary payroll practices until 12 months after the date           such termination is
effective and Executive shall be entitled to receive           Benefits during the same
twelve month period.  

7.     NON-DISCLOSURE
COVENANT; EMPLOYEE INVENTIONS  

    7.1        Acknowledgments
by the Executive. The Executive acknowledges that (a) during the Employment Period
and as a part of his employment, the Executive will be afforded access to Confidential
Information; (b) public disclosure of such Confidential Information could have an adverse
effect on the Employer and its business; (c) because the Executive possesses substantial
technical expertise and skill with respect to the Employer’s business, the Employer
desires to obtain exclusive ownership of each Employee Invention, and the Employer will
be at a substantial competitive disadvantage if it fails to acquire exclusive ownership
of each Employee Invention; and (d) the provisions of this Section 7 are
reasonable and necessary to prevent the improper use or disclosure of Confidential
Information and to provide the Employer with exclusive ownership of all Employee
Inventions.  

    7.2        Agreements
of the Executive. In consideration of the compensation and benefits to be paid or
provided to the Executive by the Employer under this Agreement, the Executive covenants
as follows:  

7 

    
        (a)        Confidentiality.
 

          		    
        (i)       
               During and following the Employment Period, the Executive will hold in
               confidence the Confidential Information and will not disclose it to any person
               except with the specific prior written consent of the Employer or except as
               otherwise expressly permitted by the terms of this Agreement. 

               

          		
            (ii)       
               Any trade secrets of the Employer will be entitled to all of the protections and
               benefits under the Colorado Uniform Trade Secrets Act, as in effect on the date
               hereof, and as amended from time to time, and any other applicable law. If any
               information that the Employer deems to be a trade secret is found by a court of
               competent jurisdiction not to be a trade secret for purposes of this Agreement,
               such information will, nevertheless, be considered Confidential Information for
               purposes of this Agreement. The Executive hereby waives any requirement that the
               Employer submit proof of the economic value of any trade secret or post a bond
               or other security. 

               

          		
            (iii)       
               None of the foregoing obligations and restrictions applies to any part of the
               Confidential Information that the Executive demonstrates was or became generally
               available to the public other than as a result of a disclosure by the Executive. 

               

          		
            (iv)       
               The Executive will not remove from the Employer’s premises (except to the
               extent such removal is for purposes of the performance of the Executive’s
               duties at home or while traveling, or except as otherwise specifically
               authorized by the Employer) any document, record, notebook, plan, model,
               component, device, or computer software or code, whether embodied in a disk or
               in any other form (collectively, the “Proprietary Items”). The
               Executive recognizes that, as between the Employer and the Executive, all of the
               Proprietary Items, whether or not developed by the Executive, are the exclusive
               property of the Employer. Upon termination of this Agreement by either party, or
               upon the request of the Employer during the Employment Period, the Executive
               will return to the Employer all of the Proprietary Items in the Executive’s
               possession or subject to the Executive’s control, and the Executive shall
               not retain any copies, abstracts, sketches, or other physical embodiment of any
               of the Proprietary Items. 

               

         
        (b)       
          Employee Inventions. Until this Agreement is terminated, each Employee
          Invention will belong exclusively to the Employer. The Executive acknowledges
          that the Executive’s writing, works of authorship, and other Employee
          Inventions are works made for hire and the property of the Employer, including
          any copyrights, patents, or other intellectual property rights pertaining
          thereto. The Executive covenants that he will promptly: 

          		
            (i)       
               disclose to the Employer in writing any Employee Invention; 

               

          		
            (ii)       
               assign to the Employer or to a party designated by the Employer, at the
               Employer’s request and without additional compensation, all of the
               Executive’s right to the Employee Invention for the United States and all
               foreign jurisdictions; 

               

8 

          		    
        (iii)       
               execute and deliver to the Employer such applications, assignments, and other
               documents as the Employer may request in order to apply for and obtain patents
               or other registrations with respect to any Employee Invention in the United
               States and any foreign jurisdictions; 

               

          		    
        (iv)       
               sign all other papers necessary to carry out the above obligations; and 

               

          		    
        (v)       
               give testimony and render any other assistance, without expense to the
               Executive, in support of the Employer’s rights to any Employee Invention. 

               

    7.3        Disputes
or Controversies. The Executive recognizes that should a dispute or controversy
arising from or relating to this Agreement be submitted for adjudication to any court,
arbitration panel, or other third party, the preservation of the secrecy of Confidential
Information may be jeopardized. All pleadings, documents, testimony, and records relating
to any such adjudication will be maintained in secrecy and will be available for
inspection by the Employer, the Executive, and their respective attorneys and experts,
who will agree, in advance and in writing, to receive and maintain all such information
in secrecy, except as may be limited by them in writing.  

8.     NON-COMPETITION
AND NON-INTERFERENCE  

    8.1        Acknowledgments
by the Executive. The Executive acknowledges that: (a) the services to be performed
by him under this Agreement are of a special, unique, unusual, extraordinary, and
intellectual character; (b) the Employer’s business is expected to be international
in scope and its products are expected to be marketed throughout the world; (c) the
Employer competes with other businesses that are or could be located in any part of the
world; and (d) the provisions of this Section 8 are reasonable and necessary
to protect the Employer’s business.  

    8.2        Covenants
of the Executive. In consideration of the acknowledgments by the Executive, and in
consideration of the compensation and benefits to be paid or provided to the Executive by
the Employer, the Executive covenants that he will not, directly or indirectly:  

         
        (a)       
          during the Employment Period, except in the course of his employment hereunder,
          and during the Post-Employment Period, engage or invest in, own, manage,
          operate, finance, control, or participate in the ownership, management,
          operation, financing, or control of, be employed by, associated with, or in any
          manner connected with, lend the Executive’s name or any similar name to,
          lend Executive’s credit to or render services or advice to, any business
          whose products or activities involve the use of mobile digital video;
          provided, however, that the Executive may purchase or otherwise acquire
          up to (but not more than) one percent of any class of securities of any
          enterprise (but without otherwise participating in the activities of such
          enterprise) if such securities are listed on any national or regional securities
          exchange or have been registered under Section 12(g) of the Securities Exchange
          Act of 1934; 

9 

         
        (b)       
          whether for the Executive’s own account or for the account of any other
          person, at any time during the Employment Period and the Post-Employment Period,
          solicit business of the same or similar type being carried on by the Employer,
          from any person known by the Executive to be a customer of the Employer, whether
          or not the Executive had personal contact with such person during and by reason
          of the Executive’s employment with the Employer; 

         
        (c)       
          whether for the Executive’s own account or the account of any other person
          (i) at any time during the Employment Period and the Post-Employment Period,
          solicit, employ, or otherwise engage as an employee, independent contractor, or
          otherwise, any person who is or was an employee of the Employer at any time
          during the Employment Period or in any manner induce or attempt to induce any
          employee of the Employer to terminate his employment with the Employer; or
          (ii) at any time during the Employment Period and for two years thereafter,
          interfere with the Employer’s relationship with any person, including any
          person who at any time during the Employment Period was an employee, contractor,
          supplier, or customer of the Employer; or 

         
        (d)       
          at any time during or after the Employment Period, publicly disparage the
          Employer or any of its shareholders, directors, officers, employees, or agents. 

        For
purposes of Section 8.2(a), (b) and (c), the term “Post-Employment
Period” commences on the date of termination of the Executive’s employment with
the Employer and continues for the six month period thereafter. Provided, that, at the
election of the Employer, such period may be extended for up to 12 additional months by
notice from the Employer to the Executive within 30 days of termination of the
Executive’s employment with the Employer. If Employer exercises this right by
providing timely notice to Executive of Employer’s exercise of this right and the
number of months (not to exceed 12) that Employer has elected to extend the
Post-Employment Period, the Employer shall during each month so extended pay Executive at
a rate equal to the greater of: (i) 66.7% of the Executive’s monthly Salary at
termination; or (ii) the amount payable under Section 6.5 (g), and shall continue for such
period any Benefits the Executive was receiving at termination. Provided further, that in
the event of termination after a Change in Control as provided in Section 6.5(g), the term
“Post-Employment Period” in this Section 8.2 shall mean the 12-month period
beginning on the date of termination of the Executive’s employment with the Employer
and the Employer shall have no right to further extend the period pursuant to this Section
8.2. 

        If
any covenant in this Section 8.2 is held to be unreasonable, arbitrary, or against
public policy, such covenant will be considered to be divisible with respect to scope,
time, and geographic area, and such lesser scope, time, or geographic area, or all of
them, as a court of competent jurisdiction may determine to be reasonable, not arbitrary,
and not against public policy, will be effective, binding, and enforceable against the
Executive. 

        The
period of time applicable to any covenant in this Section 8.2 will be extended by
the duration of any violation by the Executive of such covenant. 

        The
Executive will, while the covenant under this Section 8.2 is in effect, give notice
to the Employer, within 10 days after accepting any other employment, of the identity of
the Executive’s employer. The Employer may notify such employer that the Executive is
bound by this Agreement and, at the Employer’s election, furnish such employer with a
copy of this Agreement or relevant portions thereof. 

10 

9.     GENERAL
PROVISIONS  

    9.1        Injunctive
Relief and Additional Remedy. The Executive acknowledges that the injury that would
be suffered by the Employer as a result of a breach of the provisions of this Agreement
(including any provision of Sections 7 and 8) would be irreparable and
that an award of monetary damages to the Employer for such a breach would be an
inadequate remedy. Consequently, the Employer will have the right, in addition to any
other rights it may have, to obtain injunctive relief to restrain any breach or
threatened breach or otherwise to specifically enforce any provision of this Agreement,
and the Employer will not be obligated to post bond or other security in seeking such
relief. Without limiting the Employer’s rights under this Section 9 or
any other remedies of the Employer, if the Executive breaches any of the provisions of Section 7 or
8, the Employer will have the right to cease making any payments otherwise due to
the Executive under this Agreement.  

    9.2        Covenants
of Sections 7 and 8 Are Essential and Independent Covenants. The covenants by
the Executive in Sections 7 and 8 are essential elements of this
Agreement, and without the Executive’s agreement to comply with such covenants, the
Employer would not have entered into this Agreement or employed or continued the
employment of the Executive. The Employer and the Executive have independently consulted
their respective counsel and have been advised in all respects concerning the
reasonableness and propriety of such covenants, with specific regard to the nature of the
business conducted by the Employer.  

        The
Executive’s covenants in Sections 7 and 8 are independent
covenants and the existence of any claim by the Executive against the Employer under this
Agreement or otherwise, will not excuse the Executive’s breach of any covenant in Section 7 or
8.  

        If
the Executive’s employment hereunder expires or is terminated, this Agreement will
continue in full force and effect as is necessary or appropriate to enforce the covenants
and agreements of the Executive in Sections 7 and 8. 

    9.3               Representations
and Warranties by the Executive. The Executive represents and warrants to the
Employer that the execution and delivery by the Executive of this Agreement do not, and
the performance by the Executive of the Executive’s obligations hereunder will not,
with or without the giving of notice or the passage of time, or both: (a) violate any
judgment, writ, injunction, or order of any court, arbitrator, or governmental agency
applicable to the Executive; or (b) conflict with, result in the breach of any provisions
of or the termination of, or constitute a default under, any agreement to which the
Executive is a party or by which the Executive is or may be bound.  

    9.4        Waiver.
The rights and remedies of the parties to this Agreement are cumulative and not
alternative. Neither the failure nor any delay by either party in exercising any right,
power, or privilege under this Agreement will operate as a waiver of such right, power,
or privilege, and no single or partial exercise of any such right, power, or privilege
will preclude any other or further exercise of such right, power, or privilege or the
exercise of any other right, power, or privilege. To the maximum extent permitted by
applicable law, (a) no claim or right arising out of this Agreement can be discharged by
one party, in whole or in part, by a waiver or renunciation of the claim or right unless
in writing signed by the other party; (b) no waiver that may be given by a party will be
applicable except in the specific instance for which it is given; and (c) no notice to or
demand on one party will be deemed to be a waiver of any obligation of such party or of
the right of the party giving such notice or demand to take further action without notice
or demand as provided in this Agreement.  

11 

    9.5        Binding
Effect; Delegation of Duties Prohibited. This Agreement shall inure to the benefit
of, and shall be binding upon, the parties hereto and their respective successors,
assigns, heirs, and legal representatives, including any entity with which the Employer
may merge or consolidate or to which all or substantially all of its assets may be
transferred. The duties and covenants of the Executive under this Agreement, being
personal, may not be delegated.  

    9.6        Notices.
All notices, consents, waivers, and other communications under this Agreement must be in
writing and will be deemed to have been duly given when (a) delivered by hand (with
written confirmation of receipt), (b) sent by facsimile (with written confirmation of
receipt), provided that a copy is mailed by registered mail, return receipt requested, or
(c) when received by the addressee, if sent by a nationally recognized overnight delivery
service (receipt requested), in each case to the appropriate addresses and facsimile
numbers set forth below (or to such other addresses and facsimile numbers as a party may
designate by notice to the other parties):  

			
		If to Employer:     

                    

                    

                    

If to the Executive:

                    

                    
	Security With Advanced Technology, Inc.

489 Denver Avenue

Loveland, CO  80537

Fax: (970) 461-0717

Scott G. Sutton

1300 Laurel Street

Broomfiled, CO  80020

    9.7        Entire
Agreement; Amendments. This Agreement, Exhibit A attached hereto and the Plan
of Merger contain the entire agreement between the parties with respect to the subject
matter hereof and supersede all prior agreements and understandings, oral or written,
between the parties hereto with respect to the subject matter hereof. In addition,
simultaneously upon the execution hereof, the Employer and the Executive shall enter into
the Registration Rights Agreement in the form attached hereto as Exhibit A. This
Agreement may not be amended orally, but only by an agreement in writing signed by the
parties hereto.  

    9.8
        
Governing
Law. This Agreement will be governed by the laws of the State of Colorado without
regard to conflicts of laws principles.  

    9.9
       Jurisdiction.
Any action or proceeding seeking to enforce any provision of, or based on any right
arising out of, this Agreement may be brought against either of the parties in the courts
of the State of Colorado, County of Larimer or, if it has or can acquire jurisdiction, in
the United States District Court located in Denver, Colorado, and each of the parties
consents to the jurisdiction of such courts (and of the appropriate appellate courts) in
any such action or proceeding and waives any objection to venue laid therein. Process in
any action or proceeding referred to in the preceding sentence may be served on either
party anywhere in the world.  

12 

    9.10        Section
Headings, Construction. The headings of Sections in this Agreement are provided for
convenience only and will not affect its construction or interpretation. All references
to “Section” or “Sections” refer to the corresponding Section or
Sections of this Agreement unless otherwise specified. All words used in this Agreement
will be construed to be of such gender or number, as the circumstances require. Unless
otherwise expressly provided, the word “including” does not limit the preceding
words or terms.  

    9.11        Severability.
If any provision of this Agreement is held invalid or unenforceable by any court of
competent jurisdiction, the other provisions of this Agreement will remain in full force
and effect. Any provision of this Agreement held invalid or unenforceable only in part or
degree will remain in full force and effect to the extent not held invalid or
unenforceable.  

    9.12        Counterparts.
This Agreement may be executed in one or more counterparts, each of which will be deemed
to be an original copy of this Agreement and all of which, when taken together, will be
deemed to constitute one and the same agreement.  

    9.13        
Waiver
of Jury Trial. THE PARTIES HERETO HEREBY WAIVE A JURY TRIAL IN ANY LITIGATION WITH
RESPECT TO THIS AGREEMENT.  

        IN
WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date
above first written above.  

		
		EMPLOYER:

Security With Advanced Technology, Inc.

By: /s/ Gregory Pusey

Name: Gregory Pusey 

Title: Chairman 

EXECUTIVE:

/s/ Scott G. Sutton

Scott G. Sutton 

13Exhibit 10.12 

SECURITIES PURCHASE
AGREEMENT  

THIS SECURITIES PURCHASE
AGREEMENT (this “Agreement”) is made and entered into as of the
9th day of April, 2007 (the “Effective Date”) by and between
Security With Advanced Technology, Inc., a Colorado corporation (the
“Company”), and the investors set forth on Schedule I
attached hereto (each, an “Investor” and collectively, the
“Investors”). 

RECITAL  

        WHEREAS,
the Company desires to sell to the Investors, and the Investors desire to purchase from
the Company, (i) an aggregate amount of up to $6,000,000, but no less than $4,000,000, of
Convertible Promissory Notes (the “Notes”) which are convertible into
approximately 333,333 shares of the Company’s Series A Preferred Stock, no par
value per share (the “Preferred Stock”) per $1,000,000 outstanding under
the Notes, (ii) approximately 333,333 warrants to purchase shares of the Company’s
common stock, no par value per share (the “Common Stock”) per $1,000,000
invested in the offering exercisable at $4.75 per share expiring four years from the
Closing (as defined below), provided that such warrants will not be exercisable for six
months following the Closing, and (iii) approximately 333,333 warrants to purchase shares
of Common Stock per $1,000,000 invested in the offering exercisable at $9.00 per share
whose terms will mirror exactly the Company’s publicly traded warrants (symbol:
“SWATW”), provided that the “SWATW” warrants will not be exercisable
for six months following the Closing (collectively, the “Warrants” and
together with the Notes, the “Securities”). 

AGREEMENT  

        NOW,
THEREFORE, in consideration of the foregoing, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties
hereto hereby agree as follows: 

    1.        AUTHORIZATION
AND SALE OF SECURITIES.  

        
          1.1  
Purchase and Sale of Securities. At the Closing, the Company shall sell
to the Investors, and the Investors shall purchase from the Company, the Securities, in
the denominations set forth on Schedule I for aggregate proceeds to the Company of
up to $6,000,000 (the “Purchase Price”), but in no event less than
$4,000,000.  

        
          1.2
Closing.   The closing of the purchase and sale of the Securities (the “Closing”)
will take place at the offices of the Company on the Effective Date, or such other time
and location determined by the Company and the Investors (the “Closing Date”).
At the Closing: (i) the Company shall issue and deliver to the Investors duly executed
Notes in the denominations set forth on Schedule I and in the form attached hereto
as Exhibit A; (ii) the Company shall issue and deliver to the Investors duly
executed Warrants in the denominations set forth on Schedule I and in the forms
attached hereto as Exhibit B; and (iii) each Investor shall pay to the Company the
applicable Purchase Price for the Securities to be purchased by such Investor in the
amounts set forth on Schedule I by wire transfer of same day funds to the Company.  

    2.           REPRESENTATIONS
AND WARRANTIES OF THE COMPANY. The Company hereby makes the
following representations and warranties to the Investors as of the date hereof
and as of the Closing Date:  

        
          2.1
Organization and Qualification.  The Company is an entity duly incorporated,
validly existing and in good standing under the laws of the State of Colorado, with the
requisite corporate power and authority to own and use its properties and assets and to
carry on its business as currently conducted. The Company is not in violation of any of
the provisions of its Articles of Incorporation or Bylaws. The Company is duly qualified
to conduct business and is in good standing as a foreign corporation in each jurisdiction
in which the nature of the business conducted or property owned by it makes such
qualification necessary, except where the failure to be so qualified or in good standing,
as the case may be, would not have or result in (i) a material adverse effect on the
legality, validity or enforceability of this Agreement, the Notes, the Warrants or the
Registration Rights Agreement (as defined below) or the Certificate of Amendment to
Certificate of Designation (as defined below) (collectively, the “Transaction
Documents”), (ii) a material adverse effect on the business or financial
condition of the Company or (iii) a material adverse effect on the Company’s ability
to perform in any material respect on a timely basis its obligations under any
Transaction Document (any of (i), (ii) or (iii), a “Material Adverse Effect”).
The Company owns 100% of the outstanding capital stock of Vizer Group, Inc., a Colorado
corporation (“Vizer”). Vizer owns 100% of the outstanding capital stock
of Avurt International, Inc. (“Avurt,” and together with Vizer, the
“Merger Subs”). Except for the Merger Subs, the Company has no direct or
indirect subsidiaries.  

        
          2.2
Authorization; Enforceability.   The execution, delivery and performance by the
Company of the Transaction Documents, and the consummation of the transactions
contemplated thereby (including, but not limited to, the sale and delivery of the Notes
and Warrants, and the subsequent issuance of the Preferred Stock upon conversion of the
Notes, the Common Stock upon conversion of the Preferred Stock and the Common Stock upon
exercise of the Warrants) have been duly authorized, and no additional corporate or
stockholder action is required for the approval thereof (other than the approval of the
Company’s stockholders pursuant to The NASDAQ Stock Market Rule 4350(i) with respect
to the conversion of the Notes into Preferred Stock and the issuance of the Common Stock
into which the Preferred Stock is convertible). The Preferred Stock underlying the
Preferred Stock Notes, the Common Stock underlying the Preferred Stock and the Common
Stock underlying the Warrants (collectively, the “Conversion Shares”)
have been duly reserved for issuance by the Company. This Agreement and the other
Transaction Documents have been or, to the extent contemplated hereby or by the
Transaction Documents, will be duly executed and delivered and constitute, or will
constitute (as applicable), the legal, valid and binding agreement of the Company,
enforceable against the Company in accordance with their terms, except as may be limited
by bankruptcy, reorganization, insolvency, moratorium and similar laws of general
application relating to or affecting the enforcement of rights of creditors, and except
as enforceability of its obligations hereunder are subject to general principles of
equity (regardless of whether such enforceability is considered in a proceeding in equity
or at law). The Company has the requisite corporate power and authority to enter into and
to consummate the transactions contemplated by each of the Transaction Documents and
otherwise to carry out its obligations thereunder.  

        
          2.3
No Conflicts.   The execution, delivery and performance of the Transaction Documents
by the Company and the consummation by the Company of the transactions contemplated
thereby do not and will not (i) conflict with or violate any provision of the Company’s
Articles of Incorporation or Bylaws, or (ii) conflict with, or constitute a default (or
an event that with notice or lapse of time or both would become a default) under, or give
to others any rights of termination, amendment, acceleration or cancellation (with or
without notice, lapse of time or both) of, any agreement, credit facility, debt or other
instrument (evidencing a Company debt or otherwise) or other understanding to which the
Company is a party or by which any property or asset of the Company is bound or affected,
or (iii) subject to the Company’s obligation to obtain the approval of the Company’s
stockholders pursuant to The NASDAQ Stock Market Rule 4350(i), result in a violation of
any law, rule, regulation, order, judgment, injunction, decree or other restriction of
any court or governmental authority to which the Company is subject (including federal
and state securities laws and regulations), or by which any property or asset of the
Company is bound or affected, except, in the cases of clauses (ii) and (iii), where such
conflict, default or violation would not have or result in a Material Adverse Effect.  

        
          2.4
Filings, Consents and Approvals.   The Company is not required to obtain any
consent, waiver, authorization or order of, give any notice to, or make any filing or
registration with, any court or other federal, state, local or other governmental
authority or other Person in connection with the execution, delivery and performance by
the Company of the Transaction Documents, other than (i) a Form D and applicable state
“Blue Sky” filings, (ii) such as have already been obtained or such exemptive
filings as are required to be made under applicable securities laws and (iii) filing of
an additional listing application with the Nasdaq Stock Market (which will be made prior
to the Closing Date).  

        
          2.5
Issuance of the Securities.   The Securities and the Conversion Shares are duly
authorized and, when issued and paid for in accordance with the Transaction Documents,
will be duly and validly issued, fully paid and nonassessable, free and clear of all
Liens, other than any Liens created by or imposed on the holders thereof through no
action of the Company. The Company has reserved from its duly authorized capital stock
the maximum number of shares of Common Stock issuable pursuant to the Securities and the
Conversion Shares.  

        
          2.6
 Capitalization.  

        
                    (a)              The
authorized and outstanding capitalization of the Company is as described on Schedule II attached
hereto. The Company has not issued any capital           stock since such filing. All
shares of the Company’s issued and outstanding           capital stock have been
duly authorized, are validly issued and outstanding, and           are fully paid and
nonassessable. No securities issued by the Company from the           date of its
incorporation to the date hereof were issued in violation of any           statutory or
common law preemptive rights. There are no dividends which have           accrued or been
declared but are unpaid on the capital stock of the Company. All           taxes required
to be paid by the Company in connection with the issuance and any           transfers of
the Company’s capital stock have been paid. All securities of           the Company
have been issued in all material respects in accordance with the           provisions of
all applicable securities and other laws.  

        
          
          (b)              No
Person has any right of first refusal, preemptive right, right of
          participation, or any similar right to participate in the transactions
          contemplated by the Transaction Documents. Except as a result of the purchase
          and sale of the Securities and except for employee and director stock options
          under the Company’s equity compensation plans of approximately (i)
          1,674,000 outstanding warrants to purchase approximately 6,878,000 shares of
          Common Stock, and (ii) 709,000 shares of Preferred Stock, convertible into
          709,000 shares of Common Stock, there are no outstanding options, warrants,
          rights to subscribe to, calls or commitments of any character whatsoever
          relating to, or securities, rights or obligations convertible into or
          exchangeable for, or giving any Person any right to subscribe for or acquire,
          any shares of Common Stock, or contracts, commitments, understandings or
          arrangements by which the Company is or may become bound to issue additional
          shares of Common Stock, or securities or rights convertible or exchangeable
into           shares of Common Stock (“Common Stock Equivalents”). The
issue           and sale of the Securities will not obligate the Company to issue shares
of           Common Stock or other securities to any Person (other than the Investors)
and           will not result in a right of any holder of Company securities to adjust
the           exercise, conversion, exchange or reset price under such securities.  

        2.7  
Litigation. There is no action, suit, inquiry, notice of violation, proceeding or
investigation pending or, to the Knowledge of the Company, threatened against the Company
or any of its properties before or by any court, arbitrator, governmental or
administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an “Action”) which (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or the
Securities or (ii) could, if there were an unfavorable decision, have or result in a
Material Adverse Effect. Neither the Company nor to the Knowledge of the Company, any
director or officer thereof, is or has been the subject of any Action involving a claim
of violation of or liability under federal or state securities laws or a claim of breach
of fiduciary duty. To the Knowledge of the Company, there has not been and there is not
pending or contemplated, any investigation by the Securities and Exchange Commission
involving the Company or any current or former director or officer of the Company.  

        2.8  
Labor Relations. No material labor dispute exists or, to the Knowledge of the
Company, is imminent with respect to any of the employees of the Company which could have
or result in a Material Adverse Effect.  

        2.9  
Compliance. The Company (i) is not in default under or in violation of (and no
event has occurred that has not been waived that, with notice or lapse of time or both,
would result in a default by the Company), nor has the Company received notice of a claim
that it is in default under or that it is in violation of, any indenture, loan or credit
agreement or any other agreement or instrument to which it is a party or by which it or
any of its properties is bound (whether or not such default or violation has been
waived), (ii) is not in violation of any order of any court, arbitrator or governmental
body, or (iii) is not or has not been in violation of any statute, rule or regulation of
any governmental authority, including without limitation all foreign, federal, state and
local laws applicable to its business, except in the case of clauses (i) and (iii) as
would not have or reasonably be expected to result in a Material Adverse Effect.  

        2.10  
Intellectual Property.  

        
          
          (a)              The
Company has the right to use or is the sole and exclusive owner of all           right,
title and interest in and to all foreign and domestic patents, patent           rights,
trademarks, service marks, trade names, brands and copyrights (whether           or not
registered and, if applicable, including pending applications for           registration)
owned, used or controlled by the Company (collectively, the           “Rights”)
and in and to each material invention, software,           trade secret, technology,
product, composition, formula and method of process           used by the Company (the
Rights and such other items, the “Intellectual           Property”),
and, to the Knowledge of the Company, has the right to use           the same, free and
clear of any claim or conflict with the rights of others.  

        
          
          (b)              No
royalties or fees (license or otherwise) are payable by the Company to any
          Person by reason of the ownership or use of any of the Intellectual Property.  

        
          
          (c)              There
have been no claims made against the Company asserting the invalidity,           abuse,
misuse, or unenforceability of any of the Intellectual Property, and, to           the
best of the Knowledge of the Company, there are no reasonable grounds for           any
such claims.  

        
          
          (d)              The
Company has made not any claim of any violation or infringement by others of
          its rights in the Intellectual Property, and to the best of the Knowledge of
the           Company, no reasonable grounds for such claims exist.  

        
          
          (e)              The
Company has not received notice that it is in conflict with or infringing           upon
the asserted rights of others in connection with the Intellectual Property.  

    3.           REPRESENTATIONS
AND WARRANTIES OF THE INVESTORS.   Each           Investor, severally
and not jointly, hereby represents and warrants to the           Company that:  

        
          3.1  
Authorization. The Investor is duly authorized to execute the Transaction
Documents including this Agreement and when executed and delivered by the Investor, the
Transaction Documents will constitute legal, valid, and binding obligations enforceable
against the Investor in accordance with its terms, except as may be limited by applicable
bankruptcy, insolvency, reorganization or others laws of general application relating to
or affecting the enforcement of creditors’ rights generally. The execution,
delivery, and performance of the Transaction Documents and the consummation of the
transactions contemplated hereby have been duly authorized by all requisite corporate or
other necessary action on the part of the Investor.  

        
          3.2  
Investor Suitability.  

        
          
          (a)              The
Securities subscribed for hereby are being acquired by the Investor for his,
          her or its own account and for investment purposes only and not with a view to
          any resale or distribution thereof, in whole or in part, to others, and the
          Investor is not participating, directly or indirectly, in a distribution of
such           Securities and will not take, or cause to be taken, any action that would
cause           the Investor to be deemed an “underwriter” of such Securities
as           defined in Section 2(11) of the Securities Act of 1933, as amended (the
          “Act”).  

        
          
          (b)              The
Investor acknowledges that he, she or it has had the opportunity to seek
          business, financial, and legal advice as the Investor deems necessary in order
          to evaluate the merits and risks of purchasing the Securities.  

        
          
          (c)              The
Investor has had an opportunity to ask questions of, and receive           satisfactory
answers from, representatives of the Company concerning the terms           and
conditions pursuant to which the offering of the Securities is being made           and
all material aspects of the Company and its proposed business, and any           request
for such information has been fully complied with to the extent the           Company
possesses such information or can acquire it without unreasonable effort           or
expense.  

        
          
          (d)              The
Investor is an “accredited investor” within the meaning of Rule           501
of the Act.  

        
          
          (e)              The
Investor is an investor who has such knowledge and experience in financial           and
business matters as to be capable of evaluating the merits and risks of an
          investment in the Company based upon (i) the information furnished to him, her
          or it by the Company; (ii) his, her or its personal knowledge of the business
          and affairs of the Company; (iii) such additional information as he, she or it
          may have requested and has received from the Company; and (iv) the independent
          inquiries and investigations undertaken by him, her or it.  

        
          
          (f)              No
person has given any information or made any representation not contained in
          any disclosure documents referred to above or otherwise provided to the
Investor           in writing by a person employed or authorized in writing by the
Company. The           Investor understands and agrees that any information or
representation not           contained therein must not, and will not, be relied upon and
that nothing           contained therein should be construed as legal or tax advice to
the Investor.  

        
          
          (g)              No
person has made any direct or indirect representation or warranty of any kind
          to the Investor with respect to the economic return which may accrue to the
          Investor. The Investor has consulted with his, her or its own advisors with
          respect to an investment in the Company.  

       
          
          (h)              All
information, representations and warranties contained herein or otherwise           given
or made to the Company by the Investor in any other written statement or
          document delivered in connection with the transactions contemplated hereby are
          correct and complete as of the date of this Agreement and may be relied upon by
          the Company, and, if there should be any material change in such information
          prior to the Closing Date, the Investor will immediately furnish such revised
or           corrected information to the Company.  

    4.           CONDITIONS TO CLOSING.  

        
          4.1  
Payment of Purchase Price. On the Closing Date, the Investors shall
deliver to the Company the Purchase Price in accordance with the provisions of Section 1
against delivery by the Company of the Securities.  

        
          4.2  
Issuance and Delivery of the Notes and the Warrants. On the Closing Date, the
Company shall issue and deliver to the Investors duly executed Notes and Warrants in the
denominations set forth on Schedule I.  

        
          4.3  
Registration Right Agreement. On the Closing Date, the Company and the Investors
shall execute and deliver the Registration Rights Agreement in the form attached hereto
as Exhibit C(the “Registration Rights Agreement”).  

        
          4.4  
Amended Certificate of Designation. On or prior to the Closing Date, the Company
shall have filed with the Colorado Secretary of State a Certificate of Amendment to its
Certificate of Designation in the form attached hereto as Exhibit D (the
“Certificate of Amendment to Certificate of Designation”).  

        
          4.5  
Proceedings and Documents. All actions and other proceedings in
connection with the transactions contemplated at the Closing and all documents and
instruments incident thereto shall be reasonably satisfactory in form and substance to
the Company, the Investors and their respective legal counsel, and the Company and the
Investors shall have received all such counterpart originals and certified or other
copies of such documents as they may reasonably request.  

        
          4.6  
Nasdaq Additional Listing Application Approval. On or prior to the Closing Date,
the Company shall have provided to the Investors evidence of the filing by the Company
with The Nasdaq Stock Market of an Additional Listing Application with respect to the
Conversion Shares.  

    5.           ADDITIONAL
AGREEMENTS OF THE PARTIES.  

        
          5.1  
No Material Non-Public Information. Neither the Company nor any other Person
acting on its behalf has provided the Investor or its agents or counsel with any
information that will constitute material non-public information following the public
announcement of this Closing and the related Common Stock and Warrant financing. The
Company understands and confirms that each Investor shall be relying on the foregoing
representation in effecting transactions in securities of the Company in accordance with
applicable law following the public announcement of this Closing and the related Common
Stock and Warrant financing.  

        
          5.2
Indemnification.  

        
          
          (a)       Company
Indemnification. The Company agrees to indemnify and hold           harmless the
Investors, their affiliates, each of their officers, directors,           partners,
employees and agents and their respective successors and assigns, from           and
against any losses, damages, or expenses which are caused by or arise out of
          (i) any breach or default in the performance by the Company of any covenant or
          agreement made by the Company in this Agreement or in any of the Transaction
          Documents; (ii) any breach of warranty or representation made by the Company in
          this Agreement or in any of the Transaction Documents (iii) any and all third
          party actions, suits, proceedings, claims, demands, judgments, costs and
          expenses (including reasonable legal fees and expenses) incident to any of the
          foregoing.  

        
          
          (b)       Investor
Indemnification. Each Investor, severally and not jointly, agree           to
indemnify and hold harmless the Company, its affiliates, each of their
          officers, directors, employees and agents and their respective successors and
          assigns, from and against any losses, damages, or expenses which are caused by
          or arise out of (i) any breach or default in the performance by the Investor of
          any covenant or agreement made by the Investor in this Agreement or in any of
          the Transaction Documents; (ii) any breach of warranty or representation made
by           the Investor in this Agreement or in any of the Transaction Documents; and
(iii)           any and all third party actions, suits, proceedings, claims, demands,
judgments,           costs and expenses (including reasonable legal fees and expenses)
incident to           any of the foregoing.  

    6.        MISCELLANEOUS.  

        
          6.1  
Survival of Representations and Warranties. The representations, warranties of the
Company and the Investors contained in or made pursuant to this Agreement shall survive
the Closing Date for a period of one year.  

        
          6.2  
Successors and Assigns. This Agreement shall be binding upon and inure to the
benefit of the parties and their successors and permitted assigns. The Company may not
assign this Agreement or any rights or obligations hereunder without the prior written
consent of each Investor. Any Investor may assign any or all of its rights under this
Agreement to any Person to whom such Investor assigns or transfers any Securities or
Conversion Shares, provided that such transferee agrees in writing to be bound, with
respect to the transferred Securities or Conversion Shares, by the provisions hereof that
apply to the “Investors.” 

        
          6.3  
Governing Law. This Agreement shall be governed by and construed in accordance
with the domestic laws of the State of Colorado without giving effect to any choice of
law or conflict of law provision or rule (whether of the State of Colorado or any other
jurisdiction) that would cause the application of the laws of any jurisdiction other than
the State of Colorado.  

        
          6.4  
Counterparts. This Agreement may be executed in two or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute one and the
same instrument. In the event that any signature is delivered by facsimile transmission,
such signature shall create a valid and binding obligation of the party executing (or on
whose behalf such signature is executed) with the same force and effect as if such
facsimile signature page were an original thereof.  

        
          6.5  
Headings. The headings and captions used in this Agreement are used for
convenience only and are not to be considered in construing or interpreting this
Agreement. All references in this Agreement to sections, paragraphs, exhibits and
schedules shall, unless otherwise provided, refer to sections and paragraphs hereof and
exhibits and schedules attached hereto, all of which exhibits and schedules are
incorporated herein by this reference.  

        
          6.6  
Notices. Unless otherwise provided, any notice required or permitted under this
Agreement shall be given in writing and shall be deemed effectively given upon personal
delivery to the party to be notified or upon deposit with the United States Post Office,
by registered or certified mail, postage prepaid and addressed as follows:  

		
	If to the Investors, at: 

If to the Company, at:   

                         

                         

                         

                         

                         

                         

                         

                         
	The addresses set forth on Schedule I.

Security With Advanced Technology, Inc.

10855 Dover Street, Suite 1100

Westminster, CO 80021

Attn: Gregory Pusey, Chairman

with a copy to:

Brownstein Hyatt Farber Schreck, P.C.

410 Seventeenth Street, Suite 2200

Denver, CO 80202

Attn: Adam J. Agron 

or at such other address as any
Investor or the Company may designate by giving 10 days advance written notice to all
other parties. 

        
          6.7  
No Finder’s Fees. Except for a consulting fees payable by the Company to Roger
May and Robert Taggart, each party represents that it neither is nor will be obligated for any finder’s
or broker’s fee or commission in connection with this transaction. The Investors
agree to indemnify and to hold harmless the Company from any liability for any commission
or compensation in the nature of a finders’ or broker’s fee (and any asserted
liability) for which the Investors or any of their officers, partners, employees, or
representatives is responsible. The Company agrees to indemnify and hold harmless the
Investors from any liability for any commission or compensation in the nature of a finders’ or
broker’s fee (and any asserted liability) for which the Company or any of its
officers, employees or representatives is responsible.  

        
          6.8  
Attorneys’ Fees. If any action at law or in equity is necessary to enforce or
interpret the terms of this Agreement, the prevailing party shall be entitled to
reasonable attorneys’ fees, costs and necessary disbursements in addition to any
other relief to which such party may be entitled.  

        
          6.9  
Costs and Expenses. Each party to this Agreement shall be responsible for its own
fees and expenses in connection with this transaction.  

        
          6.10  
Amendments and Waivers. Any term of this Agreement may be amended and the
observance of any term of this Agreement may be waived (either generally or in a
particular instance and either retroactively or prospectively), only with the written
consent of (i) the Company and (ii) Investors holding a majority of the principal amount
of all outstanding Notes.  

        
          6.11  
Severability. If one or more provisions of this Agreement are held to be
unenforceable under applicable law, such provision(s) shall be excluded from this
Agreement and the balance of the Agreement shall be interpreted as if such provision(s)
were so excluded and shall be enforceable in accordance with its terms.  

        
          6.12  
Entire Agreement. This Agreement, together with all exhibits and schedules hereto,
constitutes the entire agreement and understanding of the parties with respect to the
subject matter hereof and supersedes any and all prior negotiations, correspondence,
agreements, understandings duties or obligations between the parties with respect to the
subject matter hereof.  

        
          6.13  
Further Assurances. From and after the date of this Agreement, upon the request of
a majority of the Investors or the Company, the Company and the Investors shall execute
and deliver such instruments, documents or other writings as may be reasonably necessary
or desirable to confirm and carry out and to effectuate fully the intent and purposes of
this Agreement.  

        
          6.14  
Defined Terms. The following terms shall have the following assigned meanings:  

        
          
          (a)              “Knowledge”,
with respect to the Company, means the actual           knowledge of any director or
executive officer of the Company without the           requirement for inquiry or
investigation.  

        
          
          (b)              “Lien” means
a lien, charge, security interest, encumbrance,           right of first refusal or other
restriction, except for a lien for current taxes           not yet due and payable and a
minor imperfection of title, if any, not material           in nature or amount and not
materially detracting from the value or impairing           the use of the property
subject thereto or impairing the operations or proposed           operations of the
Company.  

        
          
          (c)              “Person” means
an individual or corporation, partnership,           trust, incorporated or
unincorporated association, joint venture, limited           liability company, joint
stock company, government (or an agency or subdivision           thereof) or other entity
of any kind.  

        
          6.15  
Mutual Drafting. This Agreement is the result of the joint efforts of the Company
and the Investors, and each provision hereof has been subject to the mutual consultation,
negotiation and agreement of the parties and there shall be no construction against any
party based on any presumption of that party’s involvement in the drafting thereof.  

[signature page follows] 

        IN
WITNESS WHEREOF, the parties hereto have executed this Securities Purchase Agreement as of
the Effective Date. 

		
		THE COMPANY:

SECURITY WITH ADVANCED TECHNOLOGY, INC.

By:      ___________________________________

         Jeffrey G. McGonegal

         Chief Financial Officer

INVESTORS:

Name:

By:_________________________________________

Name:

Title:

Name:

By:_________________________________________

Name:

Title:

Name:

By:_________________________________________

Name:

Title:

Name:

By:_________________________________________

Name:

Title:

Schedule I  

Investor names,
addresses and Securities purchased 

	Investor Names
	
	Principal

Amount of

Promissory

Notes
	
	$4.75

Warrants
	
	SWATW

Warrants
	

	 	 	 	 	  	 	 	 	 	 	 	 
	

	Totals	 	 	$	   xxx,xxx	 	 	xxx   	 	 	xxx   	 
	

Schedule II 

Capitalization 

	Security With Advanced Technology, Inc.

Summary Cap Table
 		Shares
		Options &			
	December 31, 2006
		Authorized
		Outstanding
		Warrants
		Exercise Price

	Preferred Stock, no par value	 	 	 	 	 	 	5,000,000	 	 	 	 	 	 	 	 	 	 
	            2006 Private Offering	 	 	 	1	 	 	 	 	 	709,189	 	 	2,101,500	 	 	 $4.75 - $9.00	 
	 	 	 
	Common Stock, no par value	 	 	 	 	 	 	30,000,000	 	 	4,024,211	 	 	 	 	 	 	 
	            Vizer\Avurt Closing shares	 	 	 	2	 	 	 	 	 	754,380	 	 	 	 	 	 	 
	            2006 Private Offering	 	 	 	1	 	 		 	 	792,000	 	 	2,376,000	 	 	$4.75 - $9.00	 
				
		
	                      Total Common Shares	 	 	 	 	 	 	 	 	 	5,570,591	 	 	 	 	 	 	 
				
		
	 	 	 
	Options and warrants:	 	 
	        Incentive Stock Option Plan	 	 	 	 	 	 	1,500,000	 	 	 	 	 	1,674,000	 	 	   Avg @ $4.51	 
	        Private Offering & P.A.  Warrants	 	 	 	 	 	 	 	 	 	 	 	 	1,020,907	 	 	    Avg @ $6.42	 
	        2005 Public Warrants	 	 	 	 	 	 	 	 	 	 	 	 	1,380,000	 	 	    $9.00	 
				
		
	
	            Total instruments	 	 	 	 	 	 	 	 	 	6,279,780	 	 	8,552,407	 	 	 	 
				
		
	

Notes: 
 1.    Reflects the
Shareholders approval of the conversion of Notes Payable into Preferred
Shares 
 2.    Additional 533,333 SWAT shares are issuable upon earn-out achievement.  

Exhibit A  

Promissory Note 

Exhibit B  

Common Stock Purchase
Warrants 

Exhibit C  

Registration Rights
Agreement 

Exhibit D  

Certificate of
Amendment to Certificate of Designation

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00121-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00121-of-00352.parquet"}]]